Provided by Tiger Trade Technology Pte. Ltd.

Roivant Sciences Ltd.

28.66
+0.40001.42%
Volume:4.92M
Turnover:140.67M
Market Cap:20.51B
PE:-24.42
High:29.20
Open:28.43
Low:28.10
Close:28.26
52wk High:29.20
52wk Low:8.73
Shares:715.70M
Float Shares:467.00M
Volume Ratio:0.91
T/O Rate:1.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1734
EPS(LYR):-0.2371
ROE:-19.14%
ROA:-14.47%
PB:4.80
PE(LYR):-120.88

Loading ...

Roivant Sciences President and Immunovant CEO Eric Venker Reports Disposal of Common Shares

Reuters
·
Dec 12, 2025

Roivant Signals Major Pipeline Momentum With Accelerated Timelines

Benzinga_recent_news
·
Dec 12, 2025

Roivant Sciences Fast-Tracks Key Drug Development Programs

MT Newswires Live
·
Dec 11, 2025

BRIEF-Roivant Highlights Continued Pipeline Progress And Outlook For Company’S Next Phase Of Growth At 2025 Investor Day

Reuters
·
Dec 11, 2025

Roivant Sciences Hosts Investor Day to Unveil Pipeline Progress and Growth Strategy

Reuters
·
Dec 11, 2025

Roivant Sciences Ltd - Brepocitinib Nda Filing Expected Early 2026, Launch in 2027

THOMSON REUTERS
·
Dec 11, 2025

Roivant Sciences Ltd - Brepocitinib Phase 3 Trial in Niu Fully Enrolled, Data Expected H2 2026

THOMSON REUTERS
·
Dec 11, 2025

Roivant Sciences Ltd - Imvt-1402 Trial in D2t Ra Topline Data Expected 2026

THOMSON REUTERS
·
Dec 11, 2025

Roivant Highlights Continued Pipeline Progress and Outlook for Company’s Next Phase of Growth at 2025 Investor Day

THOMSON REUTERS
·
Dec 11, 2025

Roivant Sciences Director Daniel Allen Gold Reports Sale of Common Shares

Reuters
·
Nov 22, 2025

QVT Financial LP Reports Disposal of Roivant Sciences Ltd. Common Shares

Reuters
·
Nov 22, 2025

Roivant Sciences (ROIV) Gets a Buy from J.P. Morgan

TIPRANKS
·
Nov 21, 2025

Vivek Ramaswamy, 10% Owner, Reports Sale of Roivant Sciences Ltd. Shares

Reuters
·
Nov 18, 2025

Roivant Sciences price target raised to $23 from $20 at H.C. Wainwright

TIPRANKS
·
Nov 15, 2025

Roivant Sciences (ROIV): Evaluating Valuation After Earnings, Pipeline Wins, and Legal Milestone

Simply Wall St.
·
Nov 13, 2025

Roivant Sciences Ltd : TD Cowen Raises Target Price to $28 From $23

THOMSON REUTERS
·
Nov 12, 2025

Roivant Sciences Is Maintained at Buy by Citigroup

Dow Jones
·
Nov 12, 2025

Stock Track | Roivant Sciences Plunges 6.11% in Pre-market Following Q2 Earnings Miss and Mixed Pipeline Updates

Stock Track
·
Nov 10, 2025

Stock Track | Roivant Sciences Plunges 6.11% Pre-market Following Q2 Earnings Miss and Revenue Decline

Stock Track
·
Nov 10, 2025

Biopharma Roivant's Q2 income from operations misses

Reuters
·
Nov 10, 2025